<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36574210</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1534-6315</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Current allergy and asthma reports</Title><ISOAbbreviation>Curr Allergy Asthma Rep</ISOAbbreviation></Journal><ArticleTitle>Long-term Consequences of COVID-19: Chemosensory Disorders.</ArticleTitle><Pagination><StartPage>111</StartPage><EndPage>119</EndPage><MedlinePgn>111-119</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11882-022-01062-x</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW">A number of sequelae after acute coronavirus disease 2019 (COVID-19) significantly affect the quality of life of patients. The chemosensory disorders including olfactory dysfunction (OD) and gustatory dysfunction (GD) are two of the commonest symptoms complained by patients with COVID-19. Although chemosensory function has been reported improved in over 60% of COVID-19 patients in a short time after acute infection, it may last as a major symptom for patients with long COVID-19. This narrative review discussed current literatures on OD and GD in long COVID-19 including the prevalence, risk factors, possible mechanisms, and potential therapies.</AbstractText><AbstractText Label="RECENT FINDINGS">Although the prevalence of OD and GD has declined continuously after acute COVID-19, a considerable number of patients had persistent chemosensory disorders 3&#xa0;months to 2&#xa0;years after symptom onset. Female gender, initial severity of dysfunction, nasal congestion, emotional distress and depression, and SARS-CoV-2 variants have been identified as risk factors for persistent OD and GD in long COVID-19. The pathogenesis of OD and GD in long COVID-19 remains unknown, but may be analogous to the persistent OD and GD post common respiratory viral infection. Corticosteroids and olfactory training might be a potential choice regarding the treatment of lasting OD and GD after SARS-CoV-2 infection; however, more studies are needed to prove it. OD and GD are common long-term consequences of COVID-19 and influenced by gender, initial severity of dysfunction, emotional distress and depression, and SARS-CoV-2 variants. More studies are needed to illustrate their pathogenesis and to establish therapeutic strategies.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Liao</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Insititue of Allergy and Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Clinical Research Center for Nasal Inflammatory Diseases, Wuhan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Deng</LastName><ForeName>Yi-Ke</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Insititue of Allergy and Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Clinical Research Center for Nasal Inflammatory Diseases, Wuhan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China. zmsx77@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Insititue of Allergy and Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China. zmsx77@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Clinical Research Center for Nasal Inflammatory Diseases, Wuhan, People's Republic of China. zmsx77@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-4168-6702</Identifier><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China. zhengliuent@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Insititue of Allergy and Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China. zhengliuent@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Clinical Research Center for Nasal Inflammatory Diseases, Wuhan, People's Republic of China. zhengliuent@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Allergy Asthma Rep</MedlineTA><NlmUniqueID>101096440</NlmUniqueID><ISSNLinking>1529-7322</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000857" MajorTopicYN="Y">Olfaction Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013651" MajorTopicYN="N">Taste Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Gustatory dysfunction</Keyword><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">Olfactory dysfunction</Keyword><Keyword MajorTopicYN="N">Recovery</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>11</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36574210</ArticleId><ArticleId IdType="pmc">PMC9792936</ArticleId><ArticleId IdType="doi">10.1007/s11882-022-01062-x</ArticleId><ArticleId IdType="pii">10.1007/s11882-022-01062-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4(10):e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Healey Q, Sheikh A, Daines L, Vasileiou E. Symptoms and signs of long COVID: a rapid review and meta-analysis. J Glob Health. 2022;12:05014. doi: 10.7189/jogh.12.05014.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.12.05014</ArticleId><ArticleId IdType="pmc">PMC9125197</ArticleId><ArticleId IdType="pubmed">35596571</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T, Yan MZ, Li X, Lau EHY. Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis. Infection. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9244338</ArticleId><ArticleId IdType="pubmed">35750943</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251&#x2013;2261. doi: 10.1007/s00405-020-05965-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-05965-1</ArticleId><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinato G, Fabbris C, Polesel J, et al. Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. JAMA. 2020;323(20):2089&#x2013;2090. doi: 10.1001/jama.2020.6771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6771</ArticleId><ArticleId IdType="pmc">PMC7177631</ArticleId><ArticleId IdType="pubmed">32320008</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas-Lechuga MJ, Izquierdo-Dominguez A, Chiesa-Estomba C, et al. Chemosensory dysfunction in COVID-19 out-patients. Eur Arch Otorhinolaryngol. 2021;278(3):695&#x2013;702. doi: 10.1007/s00405-020-06266-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-06266-3</ArticleId><ArticleId IdType="pmc">PMC7447084</ArticleId><ArticleId IdType="pubmed">32844305</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng M, Wang DY, Mullol J, Liu Z. Chemosensory dysfunction in patients with COVID-19: what do we learn from the global outbreak? Curr Allergy Asthma Rep. 2021;21(2):6. doi: 10.1007/s11882-020-00987-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11882-020-00987-5</ArticleId><ArticleId IdType="pmc">PMC7857344</ArticleId><ArticleId IdType="pubmed">33537862</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouchi A, Chastang J, Miyara M, et al. Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study. Eur J Clin Microbiol Infect Dis. 2021;40(4):691&#x2013;697. doi: 10.1007/s10096-020-04056-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04056-7</ArticleId><ArticleId IdType="pmc">PMC7543958</ArticleId><ArticleId IdType="pubmed">33033955</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan C, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction and Covid-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 2020;10(7):806&#x2013;813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262089</ArticleId><ArticleId IdType="pubmed">32279441</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Borsetto D, Fabbris C, et al. Evolution of altered sense of smell or taste in patients with mildly symptomatic COVID-19. JAMA Otolaryngol Head Neck Surg. 2020;146(8):729&#x2013;732. doi: 10.1001/jamaoto.2020.1379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2020.1379</ArticleId><ArticleId IdType="pmc">PMC7333173</ArticleId><ArticleId IdType="pubmed">32614442</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramasamy K, Saniasiaya J, Abdul GN. Olfactory and gustatory dysfunctions as a clinical manifestation of Coronavirus disease 2019 in a Malaysian Tertiary Center. Annals of Otology, Rhinology &amp; Laryngology. 2020;130(5):513&#x2013;519. doi: 10.1177/0003489420963165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0003489420963165</ArticleId><ArticleId IdType="pubmed">33025798</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J, Deng YK, Wang H, et al. Self-reported taste and smell disorders in patients with COVID-19: distinct features in China. Curr Med Sci. 2021;41(1):14&#x2013;23. doi: 10.1007/s11596-021-2312-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11596-021-2312-7</ArticleId><ArticleId IdType="pmc">PMC7881907</ArticleId><ArticleId IdType="pubmed">33582900</ArticleId></ArticleIdList></Reference><Reference><Citation>Paderno A, Mattavelli D, Rampinelli V, et al. Olfactory and gustatory outcomes in COVID-19: a prospective evaluation in nonhospitalized subjects. Otolaryngol Head Neck Surg. 2020;163(6):1144&#x2013;1149. doi: 10.1177/0194599820939538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599820939538</ArticleId><ArticleId IdType="pmc">PMC7331108</ArticleId><ArticleId IdType="pubmed">32600175</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022;&#x2022; Tan BKJ, Han R, Zhao JJ, et al. Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves. BMJ. 2022;378:e069503. This meta-analysis reported that 5.6% and 4.4% of patients might develop long lasting self-reported OD and GD at 6 months post-covid-19. Women, greater initial severity of dysfunction and nasal congestion were risk factors for poor recovery of chemosensory dysfunctions.</Citation></Reference><Reference><Citation>Nguyen NN, Hoang VT, Lagier JC, Raoult D, Gautret P. Long-term persistence of olfactory and gustatory disorders in COVID-19 patients. Clin Microbiol Infect. 2021;27(6):931&#x2013;932. doi: 10.1016/j.cmi.2020.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.12.021</ArticleId><ArticleId IdType="pmc">PMC7784539</ArticleId><ArticleId IdType="pubmed">33418020</ArticleId></ArticleIdList></Reference><Reference><Citation>Biadsee A, Dagan O, Ormianer Z, Kassem F, Masarwa S, Biadsee A. Eight-month follow-up of olfactory and gustatory dysfunctions in recovered COVID-19 patients. Am J Otolaryngol. 2021;42(4):103065. doi: 10.1016/j.amjoto.2021.103065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2021.103065</ArticleId><ArticleId IdType="pmc">PMC8055924</ArticleId><ArticleId IdType="pubmed">33894627</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C, Surda P, Vaira LA, et al. Six month follow-up of self-reported loss of smell during the COVID-19 pandemic. Rhinology. 2021;59(1):26&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">33320115</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho DH, Reiter ER, Budd SG, Shin Y, Kons ZA, Costanzo RM. Quality of life and safety impact of COVID-19 associated smell and taste disturbances. Am J Otolaryngol. 2021;42(4):103001. doi: 10.1016/j.amjoto.2021.103001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2021.103001</ArticleId><ArticleId IdType="pmc">PMC7983361</ArticleId><ArticleId IdType="pubmed">33773440</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis D, Sartoretto SC, Calasans-Maia MD, Louro RS, Moraschini V. Long-term prevalence of taste and olfactory dysfunction in COVID-19 patients: a cross-sectional study. Oral Dis. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9348405</ArticleId><ArticleId IdType="pubmed">35491426</ArticleId></ArticleIdList></Reference><Reference><Citation>Teaima AA, Salem OM, Teama M, et al. Patterns and clinical outcomes of olfactory and gustatory disorders in six months: prospective study of 1031 COVID-19 patients. Am J Otolaryngol. 2022;43(1):103259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8481118</ArticleId><ArticleId IdType="pubmed">34626912</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Menegaldo A, Fabbris C, et al. Six-Month Psychophysical evaluation of olfactory dysfunction in patients with COVID-19. Chem Senses. 2021;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929204</ArticleId><ArticleId IdType="pubmed">33575808</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzatenta A, Neri G, D'Ardes D, et al. Smell and taste in severe CoViD-19: self-reported vs. testing. Front Med (Lausanne). 2020;7:589409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745760</ArticleId><ArticleId IdType="pubmed">33344476</ArticleId></ArticleIdList></Reference><Reference><Citation>Hintschich CA, Fischer R, Hummel T, Wenzel JJ, Bohr C, Vielsmeier V. Persisting olfactory dysfunction in post-COVID-19 is associated with gustatory impairment: results from chemosensitive testing eight months after the acute infection. PLoS ONE. 2022;17(3):e0265686. doi: 10.1371/journal.pone.0265686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0265686</ArticleId><ArticleId IdType="pmc">PMC8942205</ArticleId><ArticleId IdType="pubmed">35320821</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussiere N, Mei J, Levesque-Boissonneault C, et al. Chemosensory dysfunctions induced by COVID-19 can persist up to 7 months: a study of over 700 healthcare workers. Chem Senses. 2021;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8499810</ArticleId><ArticleId IdType="pubmed">34423831</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrocelli M, Cutrupi S, Salzano G, et al. Six-month smell and taste recovery rates in coronavirus disease 2019 patients: a prospective psychophysical study. J Laryngol Otol. 2021;135(5):436&#x2013;441. doi: 10.1017/S002221512100116X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S002221512100116X</ArticleId><ArticleId IdType="pmc">PMC8111201</ArticleId><ArticleId IdType="pubmed">33888166</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristillo V, Pilotto A, Cotti Piccinelli S, et al. Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection. J Am Geriatr Soc. 2021;69(10):2778&#x2013;2780. doi: 10.1111/jgs.17296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17296</ArticleId><ArticleId IdType="pmc">PMC8242714</ArticleId><ArticleId IdType="pubmed">34019707</ArticleId></ArticleIdList></Reference><Reference><Citation>Prem B, Liu DT, Besser G, et al. Long-lasting olfactory dysfunction in COVID-19 patients. Eur Arch Otorhinolaryngol. 2022;279(7):3485&#x2013;3492. doi: 10.1007/s00405-021-07153-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-021-07153-1</ArticleId><ArticleId IdType="pmc">PMC8578909</ArticleId><ArticleId IdType="pubmed">34757458</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Bordin A, Mucignat-Caretta C, Gaudioso P, et al. Comparison of self-reported symptoms and psychophysical tests in coronavirus disease 2019 (COVID-19) subjects experiencing long-term olfactory dysfunction: a 6-month follow-up study. Int Forum Allergy Rhinol. 2021;11(11):1592&#x2013;1595. This study compared the results of self-reported symptoms and psychophysical tests in COVID-19 patients with long-term OD at 6-month follow-up. The results confirmed that psychophysical smell tests were more sensitive than patient-reported outcome measures, and that the latter could be unreliable when used to assess smell recovery in the long-term.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426864</ArticleId><ArticleId IdType="pubmed">34148294</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortunato F, Martinelli D, Iannelli G, et al. Self-reported olfactory and gustatory dysfunctions in COVID-19 patients: a 1-year follow-up study in Foggia district, Italy. BMC Infect Dis. 2022;22(1):77. doi: 10.1186/s12879-022-07052-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07052-8</ArticleId><ArticleId IdType="pmc">PMC8783175</ArticleId><ArticleId IdType="pubmed">35065619</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan HQM, Pendolino AL, Andrews PJ, Choi D. Prevalence of olfactory dysfunction and quality of life in hospitalised patients 1 year after SARS-CoV-2 infection: a cohort study. BMJ Open. 2022;12(1):e054598. doi: 10.1136/bmjopen-2021-054598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-054598</ArticleId><ArticleId IdType="pmc">PMC8795927</ArticleId><ArticleId IdType="pubmed">35078845</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Martin-Guerrero JD, Navarro-Pardo E, Cancela-Cilleruelo I, Moro-Lopez-Menchero P, Pellicer-Valero OJ. Exploring trajectory curves from loss of smell and taste in previously hospitalized COVID-19 survivors: the LONG-COVID-EXP-CM Multicenter Study. J Gen Intern Med. 2022;37(7):1821&#x2013;1823. doi: 10.1007/s11606-022-07459-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07459-8</ArticleId><ArticleId IdType="pmc">PMC8863099</ArticleId><ArticleId IdType="pubmed">35194745</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreli F, Gaino F, Russo E, et al. Long-term olfactory dysfunction in COVID-19 patients: 18-month follow-up study. Int Forum Allergy Rhinol. 2022;12(8):1078&#x2013;1080. doi: 10.1002/alr.22990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22990</ArticleId><ArticleId IdType="pmc">PMC9082048</ArticleId><ArticleId IdType="pubmed">35199476</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Hummel T, Hopkins C, et al. High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-COVID-19 patients: a matched case-control study with one-year follow-up using a comprehensive psychophysical evaluation. Rhinology. 2021;59(6):517&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pubmed">34553706</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Boscolo-Rizzo P, Fabbris C, Polesel J, et al. Two-Year Prevalence and recovery rate of altered sense of smell or taste in patients with mildly symptomatic COVID-19. JAMA Otolaryngol Head Neck Surg. 2022;148(9):889&#x2013;891. This 2 years follow-up study reported that 88.2% of patients reporting a COVID-19&#x2013;related OD or GD completely recovered within 2 years. A late recovery was observed in 10.9% of patients.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9353700</ArticleId><ArticleId IdType="pubmed">35925596</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein H, Asseo K, Karni N, et al. Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients. Clin Microbiol Infect. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7884919</ArticleId><ArticleId IdType="pubmed">33607252</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinol Suppl. 2017;54(26):1&#x2013;30. doi: 10.4193/Rhino16.248.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhino16.248</ArticleId><ArticleId IdType="pubmed">29528615</ArticleId></ArticleIdList></Reference><Reference><Citation>Riestra-Ayora J, Yanes-Diaz J, Esteban-Sanchez J, et al. Long-term follow-up of olfactory and gustatory dysfunction in COVID-19: 6 months case-control study of health workers. Eur Arch Otorhinolaryngol. 2021;278(12):4831&#x2013;4837. doi: 10.1007/s00405-021-06764-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-021-06764-y</ArticleId><ArticleId IdType="pmc">PMC8004560</ArticleId><ArticleId IdType="pubmed">33774737</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso CC, Rossi AD, Galliez RM, Faffe DS, Tanuri A, Castineiras T. Olfactory dysfunction in patients with mild COVID-19 during Gamma, Delta, and Omicron Waves in Rio de Janeiro. Brazil JAMA. 2022;328(6):582&#x2013;583. doi: 10.1001/jama.2022.11006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11006</ArticleId><ArticleId IdType="pmc">PMC9364123</ArticleId><ArticleId IdType="pubmed">35749125</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271&#x2013;280 e278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Radulesco T, Calvo-Henriquez C, et al. ACE2 &amp; TMPRSS2 Expressions in head &amp; neck tissues: a systematic review. Head Neck Pathol. 2020;15(1):225&#x2013;235. doi: 10.1007/s12105-020-01212-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12105-020-01212-5</ArticleId><ArticleId IdType="pmc">PMC7439628</ArticleId><ArticleId IdType="pubmed">32816230</ArticleId></ArticleIdList></Reference><Reference><Citation>Sungnak W, Huang N, Becavin C, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681&#x2013;687. doi: 10.1038/s41591-020-0868-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0868-6</ArticleId><ArticleId IdType="pmc">PMC8637938</ArticleId><ArticleId IdType="pubmed">32327758</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Li X, Geng D, et al. Cerebral micro-structural changes in COVID-19 patients - an MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25:100484. doi: 10.1016/j.eclinm.2020.100484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100484</ArticleId><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JC, Nallani R, Cass L, Bhalla V, Chiu AG, Villwock JA. A systematic review of the neuropathologic findings of post-viral olfactory dysfunction: implications and novel insight for the COVID-19 pandemic. Am J Rhinol Allergy. 2021;35(3):323&#x2013;333. doi: 10.1177/1945892420957853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1945892420957853</ArticleId><ArticleId IdType="pmc">PMC10404900</ArticleId><ArticleId IdType="pubmed">32915650</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollndorfer K, Jakab A, Mueller CA, Trattnig S, Schopf V. Effects of chronic peripheral olfactory loss on functional brain networks. Neuroscience. 2015;310:589&#x2013;599. doi: 10.1016/j.neuroscience.2015.09.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.09.045</ArticleId><ArticleId IdType="pubmed">26415766</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini S, Wilk E, Michaelsen-Preusse K, et al. Long-term neuroinflammation induced by influenza a virus infection and the impact on hippocampal neuron morphology and function. J Neurosci. 2018;38(12):3060&#x2013;3080. doi: 10.1523/JNEUROSCI.1740-17.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1740-17.2018</ArticleId><ArticleId IdType="pmc">PMC6596076</ArticleId><ArticleId IdType="pubmed">29487124</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinoza JA, Bohmwald K, Cespedes PF, et al. Impaired learning resulting from respiratory syncytial virus infection. Proc Natl Acad Sci U S A. 2013;110(22):9112&#x2013;9117. doi: 10.1073/pnas.1217508110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1217508110</ArticleId><ArticleId IdType="pmc">PMC3670318</ArticleId><ArticleId IdType="pubmed">23650398</ArticleId></ArticleIdList></Reference><Reference><Citation>Glass WG, Subbarao K, Murphy B, Murphy PM. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J Immunol. 2004;15(173(6)).</Citation><ArticleIdList><ArticleId IdType="pubmed">15356152</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K, Wohlford-Lenane C, Perlman S, et al. Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J Infect Dis. 2016;213(5):712&#x2013;722. doi: 10.1093/infdis/jiv499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiv499</ArticleId><ArticleId IdType="pmc">PMC4747621</ArticleId><ArticleId IdType="pubmed">26486634</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbot PJ, Ekand&#xe9; S, Cashman NR, Mounir S, Stewart JN. Neurotropism of human coronavirus 229E. Adv Exp Med Biol. 1993;342.</Citation><ArticleIdList><ArticleId IdType="pubmed">8209751</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchini MP, Brozzetti L, Cardobi N, et al. Persistent chemosensory dysfunction in a young patient with mild COVID-19 with partial recovery 15 months after the onset. Neurol Sci. 2022;43(1):99&#x2013;104. doi: 10.1007/s10072-021-05635-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05635-y</ArticleId><ArticleId IdType="pmc">PMC8487402</ArticleId><ArticleId IdType="pubmed">34601698</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92(6):552&#x2013;555. doi: 10.1002/jmv.25728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25728</ArticleId><ArticleId IdType="pmc">PMC7228394</ArticleId><ArticleId IdType="pubmed">32104915</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M, Yoo S-J, Clijsters M, et al. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb. Cell. 2021;184(24):5932&#x2013;5949. doi: 10.1016/j.cell.2021.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.10.027</ArticleId><ArticleId IdType="pmc">PMC8564600</ArticleId><ArticleId IdType="pubmed">34798069</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B, Tang N, Peluso MJ, et al. Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations. Cells. 2021;10(2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitcroft KL, Hummel T. Clinical diagnosis and current management strategies for olfactory dysfunction: a review. JAMA Otolaryngol Head Neck Surg. 2019;145(9):846&#x2013;853. doi: 10.1001/jamaoto.2019.1728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2019.1728</ArticleId><ArticleId IdType="pubmed">31318413</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo BS, Lee HJ, Mo J-H, Lee CH, Rhee CS, Kim J-W. Treatment of postviral olfactory loss with glucocorticoids, Ginkgo biloba, and mometasone nasal spray. Arch Otolaryngol Head Neck Surg. 2009;135(10):1000&#x2013;1004.</Citation><ArticleIdList><ArticleId IdType="pubmed">19841338</ArticleId></ArticleIdList></Reference><Reference><Citation>Schriever VA, Merkonidis C, Gupta N, Hummel C, Hummel T. Treatment of smell loss with systemic methylprednisolone. Rhinology. 2012;50(3):284&#x2013;289. doi: 10.4193/Rhino.11.207.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhino.11.207</ArticleId><ArticleId IdType="pubmed">22888485</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DH, Kim SW, Hwang SH, et al. Prognosis of olfactory dysfunction according to etiology and timing of treatment. Otolaryngol Head Neck Surg. 2017;156(2):371&#x2013;377. doi: 10.1177/0194599816679952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599816679952</ArticleId><ArticleId IdType="pubmed">28145844</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh CV, Jain S, Parveen S. The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients. Am J Otolaryngol. 2021;42(3):102892. doi: 10.1016/j.amjoto.2020.102892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2020.102892</ArticleId><ArticleId IdType="pmc">PMC7972940</ArticleId><ArticleId IdType="pubmed">33493729</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelalim AA, Mohamady AA, Elsayed RA, Elawady MA, Ghallab AF. Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: a randomized controlled trial. Am J Otolaryngol. 2021;42(2):102884. doi: 10.1016/j.amjoto.2020.102884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2020.102884</ArticleId><ArticleId IdType="pmc">PMC7836546</ArticleId><ArticleId IdType="pubmed">33429174</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bon SD, Konopnicki D, Pisarski N, Prunier L, Lechien JR, Horoi M. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell. Eur Arch Otorhinolaryngol. 2021;278(8):3113&#x2013;3117. doi: 10.1007/s00405-020-06520-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-06520-8</ArticleId><ArticleId IdType="pmc">PMC7796691</ArticleId><ArticleId IdType="pubmed">33423106</ArticleId></ArticleIdList></Reference><Reference><Citation>Neta FI, Fernandes ACL, Vale AJM, et al. Pathophysiology and possible treatments for olfactory-gustatory disorders in patients affected by COVID-19. Curr Res Pharmacol Drug Discov. 2021;2:100035. doi: 10.1016/j.crphar.2021.100035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crphar.2021.100035</ArticleId><ArticleId IdType="pmc">PMC8178068</ArticleId><ArticleId IdType="pubmed">34870148</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinology journal. 2017;54(26):1&#x2013;30. doi: 10.4193/Rhino16.248.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhino16.248</ArticleId><ArticleId IdType="pubmed">29528615</ArticleId></ArticleIdList></Reference><Reference><Citation>Pekala K, Chandra RK, Turner JH. Efficacy of olfactory training in patients with olfactory loss: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2016;6(3):299&#x2013;307. doi: 10.1002/alr.21669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.21669</ArticleId><ArticleId IdType="pmc">PMC4783272</ArticleId><ArticleId IdType="pubmed">26624966</ArticleId></ArticleIdList></Reference><Reference><Citation>Hura N, Xie DX, Choby GW, et al. Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2020;10(9):1065&#x2013;1086. doi: 10.1002/alr.22624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22624</ArticleId><ArticleId IdType="pmc">PMC7361320</ArticleId><ArticleId IdType="pubmed">32567798</ArticleId></ArticleIdList></Reference><Reference><Citation>Denis F, Septans AL, Periers L, et al. Olfactory training and visual stimulation assisted by a web application for patients with persistent olfactory dysfunction after SARS-CoV-2 infection: observational study. J Med Internet Res. 2021;23(5):e29583. doi: 10.2196/29583.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/29583</ArticleId><ArticleId IdType="pmc">PMC8163493</ArticleId><ArticleId IdType="pubmed">34003765</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>